UBS Group »

Avalo Therapeutics Ord shares owned by UBS Group

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Avalo Therapeutics Ord

Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 20250200k400k600k050k100k
Value ($)Share countHistorical AVTX position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $732k 99k 7.43
2024-09-30 $58k 6.1k 9.50
2024-06-30 $45k 3.6k 12.50
2024-03-31 $170k 7.7k 22.00
2023-12-31 $18 2 9.00